Skip to main content

Diabetic Kidney Disease News

1990 to 2021 Saw Increase in Global Burden of Diabetic Nephropathy

MONDAY, March 17, 2025 – The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, according to a study published online Feb. 21 in...

FDA Approves Invokana (canagliflozin) to Treat Diabetic Kidney Disease (DKD) and Reduce the Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes and DKD

RARITAN, N.J., Sept. 30, 2019 /PRNewswire/ – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

lisinopril, losartan, ramipril, Invokana